Thrombocytopenia after chemotherapy in solid tumors
Conditions
Interventions
Treatment Group:None
Control Group:None
Sponsors
Affiliated Qingyuan Hospital, Guangzhou Medical University,Qingyuan People's Hospital;
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with tumors admitted to our hospital; 2. Thrombocytopenia after chemotherapy in our hospital, meeting the diagnostic criteria in the "Expert Consensus on Clinical Management of Thrombocytopenia Associated with Tumor Treatment (2021)", and the patient's thrombocytopenia is graded as grade II.~IV.; 3. Age over 18 years with complete clinical data records; 4. Patients who have used hetrombopag ethanolamine tablets in combination with recombinant human interleukin-11 or recombinant human interleukin-11 alone.
Exclusion criteria
Exclusion criteria: 1. Patients with thrombocytopenia not caused by chemotherapy drugs; 2. Patients who have not received chemotherapy in our hospital; 3. Primary hematologic disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gender, age, type of medication, dosage and course of treatment, and length of hospital stay of patients;Laboratory platelet count values before and after medication;Changes in coagulation function;Liver function indexes before and after medication (alanine aminotransferase, aspartate aminotransferase, bilirubin, bile); | — |
Countries
China
Contacts
Public ContactLin Jieru
Qingyuan Hospital Affiliated to Guangzhou Medical University (Qingyuan People's Hospital)
Outcome results
None listed